The second cross-sectioned study on antidepressants patterns of depression in China

司天梅,舒良,于欣,马崔,王高华,白培深,刘协和,孙立忠,师建国,陈宪生,梅其一,栗克清
DOI: https://doi.org/10.3760/cma.j.issn.1006-7884.2010.04.006
2010-01-01
Abstract:Objective To uncover the antidepressants drug use patterns for treating depression in China in 2006, and the developing tendency for past 4 years. Methods Based on economic levels in different provinces and the convenient sampling, totally 41 hospitals from 10 provinces and cities were selected out. The investigation was conducted during May 22th -28th, 2006, using the revised self-made questionnaire. Results The total number of the sample was 1354, including outpatients (68.0% ) and with pharmacotherapy, and the antidepressants most frequently prescribed were paroxetine (24.4% of the 1354 patients), fluoxetine (20.3% ), venlafaxine (19.5%), citalopram (11.0%), sertraline (6.3% ),and mirtazapine (4.1% ), while 219 patients ( 17.1% ) were treated with TCAs. 62.3% of patients were treated with SSRIs, and most of them administered monotherapy. The frequency of benzodiazepine,antipsychotics and mood stabilizers used were 43.6%, 20.8% and 6.5%, respectively. Comparing to the outpatients, the frequency to use the benzodiazepine and antipsychotics for the inpatients was higher (P < 0.05). And more patients in acute phase used benzodiazepine than those who were in maintenance phase (P < 0.01 ). Conclusion Novel antidepressants are the mainstream to treat patients with depression in China, the tendency of antidepressants prescription pattern matches the development of treatment outcome and treatment techniques for depression.
What problem does this paper attempt to address?